Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| TASIGNA® - Nilotinib | 2013-07-14 | Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA®. |
|